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Abstract
With the shift of molecular technologies directed toward the understanding of 
greater biological complexity of the oral cavity, a knowledge gap was created by the 
lack of genomic data from the diverse oral microorganisms. To facilitate and enable 
the interpretation of metagenomic, transcriptomic, and proteomic data generated 
or soon to be generated from oral biofilms, we are providing reference genomic 
information from phylogenetically diverse oral bacterial isolates. This work, initiated 
by the National Institute of Dental and Craniofacial Research as an isolated effort, 
is now part of the Human Microbiome Project. The goal of this effort is the public 
release of genomic data in support of functional and phylogenetic analyses of the 
complex oral microbiome. The genomic information acquired will be a key com-
ponent in understanding the interaction of the oral biofilms with the human host 
and in developing novel healthcare strategies to prevent and treat oral diseases. 
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Introduction 
The human oral biofilms are readily accessible complex bacterial com-
munities. Although it is one of the best-characterized microbiomes at 
the phylogenetic level, its internal dynamics and relationship to the 
host remain a mystery. This abundant self-renewable biofilm is respon-
sible for oral health as well as diseases of both hard and soft tissues 
of the oral cavity. In addition, evidence is accumulating to indicate the 
microbiome’s significant influence on overall health, through a direct 
interactive exchange between the host response and the members of 
the oral microbiome [1–3]. Bacterial complexes are involved in those 
processes, and no individual pathogen can be singled out [4–7]. 
Bacterial diversity is a key characteristic of dental sub and supra-
gingival plaque as well as the biofilms on other oral surfaces includ-
ing the gingiva, tongue, hard palate, and cheeks. To date, over 600 
bacterial species and a single archaea species have been identified as 
members of the oral community [5, 8, 9]. This number is increasing as 
more studies are performed all over the world. The added diversity 
may be related to disease status, regional environmental factors, or 
diet. For example, one might expect that the oral flora of a subject 
with a diet rich in raw fish with high fatty acid content will differ from 
the flora of a vegan subject. Such population changes have been well 
demonstrated in subjects with periodontitis compared with healthy 
subjects [4, 6, 10]. This underscores the interplay between the bacterial 
members of the oral biofilms, the host’s physiological reactions and 
the fact that the mouth is an open system to the environment. Foods 
and fluids that we ingest as well as air that we breathe are significant 
sources of new bacterial challenges on a daily basis. 
The extent of the morphological diversity of the bacteria in the 
oral cavity is astonishing. The highly motile spiral of the treponemes 
might coexist with the gliding multicellular-filamentous species of 
the genus Simonsiella, the corncob arrangements of Corynebacterium 
matruchotii or Fusobacterium nucleatum with Streptococcus sanguis, 
as well as cocci, short and long rods [11–14]. The phylogenetic di-
versity encompasses at least 12 phyla and over 170 genera [8]. The 
genera include cultivable named species (47%), cultivable yet-to-be-
named species (18%), and yet-to-be-cultivated phylotypes, which of-
ten wear the inaccurate label of uncultivable in the literature (35%). 
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These numbers are always fluctuating as the naming of organisms 
is an ongoing process [14, 15], and novel culture methods are being 
developed. 
The variety of organisms, mentioned above, results in a diverse 
genetic potential that is mostly untapped and unknown. How those 
bacteria produce pathogenic factors, resist antibiotics, evade host im-
mune response, communicate with each others, or simply use nutri-
ents for their own energy production is mostly a mystery. The genetic 
characteristics of these oral bacteria are unknown because most of 
them are considered commensal and have not been the focus of many 
studies. Other factors detrimental to their study are their fastidious 
growth characteristics compared to Escherichia coli or Bacillus subtilis 
and their lack of established genetic systems. 
While metagenomics, transcriptomics, and proteomics are part of 
the next key steps of understanding complex systems, they all rely on 
availability of the genomic sequence to decipher the content of the 
dataset via similarities to better known systems. These similarities pro-
vide the original clues toward function and phylogenetic attribution. 
With the absence of such data for most of the oral microbiome mem-
bers, the scientific community was likely at risk to miss some of the 
benefits from the ongoing technological advances in the omic world. 
Those advances touch all aspects of fields looking at a large-scale 
analysis of a genome, a proteome, or a metabolome, just to name a 
few. Prior to joining the Human Microbiome project, we provided ge-
nome surveys to the community (Table 1). Genome surveying is a low 
cost approach to provide anchoring genetic data for metagenomic 
analysis of obscure branches of the phylogenetic tree. Genetic libraries 
were created, and 12 organisms from 6 phyla were sequenced (Table 
1). A minimum of 350,000 bases were recovered and annotated per 
genome (Table 1). A novel annotation pipeline was created to accom-
modate the short contigs generated by low sequencing coverage of 
random genomic libraries (Dewhirst et al. unpublished data) [8, 15]. 
This took advantage of the lengths of the singlets (single sequencing 
read) and the contigs (assembly of two or more sequencing reads) 
that may not cover the full length of the open reading frame but are 
sufficient to ascertain similarities and to provide matching sequences 
to pyrosequencing generated short reads. The dynamic annotation, 
updated periodically, for each genome survey is available online at 
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the Human Oral Microbiome database (http://www.homd.org) [8]. The 
manual annotation of Pyramidobacter piscolens genome survey data 
was published when the organism was named [16]. 
With the announcement of the Human Microbiome Project, another 
era of bacterial genome sequencing began [17]. Becoming a member 
of this scientific endeavor allowed the transition from the production 
of genome surveys to the sequencing of full genomes by pyrose-
quencing. This is being done in partnership with four genomic centers: 
the Broad Institute of MIT and Harvard, the J. Craig Venter Institute, 
the Genome Sequencing Center at Washington University, and the 
Human Genome Sequencing Center at the Baylor College of Medicine. 
Now, with the first 50 bacterial genomes provided to the centers for 
sequencing, we look forward to closing the gap in describing genetic 
and phylogenetic diversity. The progress done can be monitored at 
the Human Microbiome Project website (http://www.hmpdacc.org) 
and at the Human Oral Microbiome database. In addition, the bacte-
rial strains are provided to the Biodefense and Emerging Infections 
Research Resources Repository at ATCC (http://www.beiresources.org) 
for availability to the scientific community at large. For phylogenetic 
studies, the essentially full sequences of the 16S ribosomal RNA gene 
are also provided to GenBank repository. 
Table 1. Genome survey data produced and released in Genbank 
      No. of  Combined  Genbank  
    Taxon  SEQF  contigs  length  accession  
Phylum  Genus  Species  Strain  IDa  IDb  & singlets  (Kbp)  number 
Bacteroidetes  Prevotella  sp. oral taxon 302  F0020  302  1,020  404  362  FI090687-FI091098 
Firmicutes  Bulleidia  extructa  W1219  603  1,088  350  385  ET629122-ET629476 
Firmicutes  Eubacterium  infirmum  ATCC 700433  105  1,108  413  409  ET630587-ET631005 
Firmicutes  Solobacterium  moorei  W5408  678  1,152  338  354  ET631874-ET632213 
Firmicutes  Veillonella  parvula  ATCC 17745  161  1,058  353  372  ET632214-ET632569 
Fusobacteria  Leptotrichia  buccalis  ATCC 14201  563  1,028  345  392  ET631526-ET631873 
Proteobacteria  Campylobacter  gracilis  ATCC 33236  623  1,005  384  402  ET629477-ET629866 
Proteobacteria  Campylobacter  rectus  ATCC 33238  748  1,089  356  353  ET629867-ET630228 
Proteobacteria  Campylobacter  showae  ATCC 51146  763  1,091  352  340  ET630229-ET630586 
Spirochaetes  Treponema  lecithinolyticum  OMZ 684T  653  1,060  1,377  1,469  ET632570-ET633946 
Synergistetes  Jonquetella  anthropi  E3_33 E1  777  1,476  509  618  ET631006-ET631525 
Synergistetes  Pyramidobacter  piscolens  W5455  357  1,541  852  615  DU723013-DU723395 
      Total  6,033 
a. Taxon ID refers to a phylotype designation as part of the investigation of phylogenetic diversity of the oral microbiome,  
http://www.homd.org 
b. SEQF ID is a unique identifier of bacterial genomes sequenced from a unique isolate from a specific laboratory  
http://www.homd.org   
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How will this benefit the patient? With the acceptance that oral 
bacteria are part of the equation for good oral health, it becomes im-
portant to ensure that day-to-day treatments (toothpastes, oral rinses, 
etc.) are not damaging the host immune response or suppressing of 
the most critical group of bacteria involved in oral health. Moving 
toward prevention requires an unprecedented effort to understand 
what health is. It is also important to understand what the organ-
isms’ proportions are, which bacterial complexes are prevalent, which 
metabolic pathways are shared, which part of the genomic potential is 
expressed (transcriptomics), what the composition of a bacteria in the 
biofilm (proteomics) is, and consequently which abundant potential 
peptide targets are available for drug design and which metabolites 
are released (metabolomics) and could be targets for inhibitors. Ge-
netic studies of both the normal and the pathogenic flora will be, as 
they have been in the past, a key element to develop drug therapies 
[18, 19]. Discovering the components contributing to health at the 
microbiome level can lead to clinical strategies to maintain a healthy 
balance between the microbiome and the host response.  
The next steps are for the scientific community to expand the work 
of isolating new strains and providing genomic sequence informa-
tion. This process will improve our ability to understand how the oral 
microbiome self-organizes and interacts with the host. This host in-
teraction is a key component in the dynamic interplay, leading to the 
maintenance of oral health as well as the population shifts resulting 
in chronic diseases such as caries and periodontitis. Increased under-
standing of the behavior of the oral biofilms through transcriptomics, 
proteomics, interactomics, functomics, and many other “omic” disci-
plines relies on the available genomic data, and will open new avenues 
for treatment strategies. 
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